Stockholders' equity increased 28.3%
Stockholders' equity changed +28.3% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Stockholders' equity changed +28.3% from the comparable as-filed period.
Free-cash-flow proxy changed +285.4% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Revenue changed +9.9% from the comparable as-filed period.
Gross margin changed +153 basis points from the comparable as-filed period.
Debt / equity changed -6355 basis points from the comparable as-filed period.
Debt / revenue changed -565 basis points from the comparable as-filed period.
Operating cash flow changed +424.5% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Working capital / assets changed +541 basis points from the comparable as-filed period.
Cash & equivalents changed +17.0% from the comparable as-filed period.
Current liabilities changed +14.1% from the comparable as-filed period.
Total assets changed +12.9% from the comparable as-filed period.
Cash / debt changed +1746 basis points from the comparable as-filed period.
Free-cash-flow margin changed +1806 basis points from the comparable as-filed period.
Operating cash-flow margin changed +1783 basis points from the comparable as-filed period.
Trade receivables changed +15.0% from the comparable as-filed period.
Receivables / revenue changed +216 basis points from the comparable as-filed period.
Gross profit changed +12.7% from the comparable as-filed period.
Debt / assets changed -194 basis points from the comparable as-filed period.
Inventory / revenue changed -89 basis points from the comparable as-filed period.
Inventory changed +6.7% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Working capital changed +123.6% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Capex / revenue changed -23 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
R&D / revenue changed -166 basis points from the comparable as-filed period.
SBC / revenue changed -73 basis points from the comparable as-filed period.
Current ratio changed +11.8% from the comparable as-filed period.
Cost of revenue changed +5.7% from the comparable as-filed period.
Gross debt changed +0.3% from the comparable as-filed period. The change ranks at the 0th percentile of 6 prior comparable changes. This reverses 6 consecutive comparable moves in the opposite direction.
Research & development changed +0.1% from the comparable as-filed period.
Stock-based compensation changed -1.5% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Capital expenditure changed -1.4% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Operating cash flow / net income changed +213.9% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Net debt changed -147.6% from the comparable as-filed period.
Inventory / revenue changed -1650 basis points from the comparable as-filed period.
Shares outstanding changed -1.8% from the comparable as-filed period. The change ranks at the 71th percentile of 7 prior comparable changes. This reverses 6 consecutive comparable moves in the opposite direction.
Working capital changed -45.5% from the comparable as-filed period.
Cash / debt changed +363 basis points from the comparable as-filed period.
Current liabilities changed +15.9% from the comparable as-filed period.
Revenue changed +11.4% from the comparable as-filed period.
Cash & equivalents changed +13.3% from the comparable as-filed period.
Current assets changed +13.7% from the comparable as-filed period.
Receivables / revenue changed +1636 basis points from the comparable as-filed period.
Operating cash-flow margin changed -606 basis points from the comparable as-filed period.
Operating cash flow / net income changed -84.5% from the comparable as-filed period.
Gross debt changed +9.4% from the comparable as-filed period. The change ranks at the 40th percentile of 5 prior comparable changes. This reverses 5 consecutive comparable moves in the opposite direction.
Total assets changed +9.0% from the comparable as-filed period.
Noncurrent long-term debt changed -10.8% from the comparable as-filed period.
Gross margin changed +6 basis points from the comparable as-filed period.
Working capital / assets changed -110 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Gross profit changed +11.5% from the comparable as-filed period.
Research & development changed +6.3% from the comparable as-filed period.
Cost of revenue changed +11.2% from the comparable as-filed period.
SBC / revenue changed -28 basis points from the comparable as-filed period.
Debt / revenue changed -111 basis points from the comparable as-filed period.
Current ratio changed -1.9% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Debt / assets changed +6 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
R&D / revenue changed -88 basis points from the comparable as-filed period.
Stock-based compensation changed +6.9% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.